Abstract
Efficiency and accuracy in addressing drug safety issues proactively are critical in minimizing late-stage drug attritions. Discovery Toxicology has become a specialty subdivision of Toxicology seeking to effectively provide early predictions and safety assessment in the drug discovery process. Among the many technologies utilized to select safer compounds for further development, in vitro imaging technology is one of the best characterized and validated to provide translatable biomarkers towards clinically-relevant outcomes of drug safety. By carefully applying imaging technologies in genetic, hepatic, and cardiac toxicology, and integrating them with the rest of the drug discovery processes, it was possible to demonstrate significant impact of imaging technology on drug research and development and substantial returns on investment.
Keywords: Translational medicine, lead optimization, genetic toxicology, hepatotoxicity, cardiac safety screens, Ames, micronucleus, idiosyncratic drug induced liver injury, phospholipidosis, and cardiotoxicity test
Combinatorial Chemistry & High Throughput Screening
Title: “Seeing is Believing”: Perspectives of Applying Imaging Technology in Discovery Toxicology
Volume: 12 Issue: 9
Author(s): Jinghai James Xu, Margaret Condon Dunn and Arthur Russell Smith
Affiliation:
Keywords: Translational medicine, lead optimization, genetic toxicology, hepatotoxicity, cardiac safety screens, Ames, micronucleus, idiosyncratic drug induced liver injury, phospholipidosis, and cardiotoxicity test
Abstract: Efficiency and accuracy in addressing drug safety issues proactively are critical in minimizing late-stage drug attritions. Discovery Toxicology has become a specialty subdivision of Toxicology seeking to effectively provide early predictions and safety assessment in the drug discovery process. Among the many technologies utilized to select safer compounds for further development, in vitro imaging technology is one of the best characterized and validated to provide translatable biomarkers towards clinically-relevant outcomes of drug safety. By carefully applying imaging technologies in genetic, hepatic, and cardiac toxicology, and integrating them with the rest of the drug discovery processes, it was possible to demonstrate significant impact of imaging technology on drug research and development and substantial returns on investment.
Export Options
About this article
Cite this article as:
Xu James Jinghai, Dunn Condon Margaret and Smith Russell Arthur, “Seeing is Believing”: Perspectives of Applying Imaging Technology in Discovery Toxicology, Combinatorial Chemistry & High Throughput Screening 2009; 12 (9) . https://dx.doi.org/10.2174/138620709789383268
DOI https://dx.doi.org/10.2174/138620709789383268 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Trastuzumab-Induced Cardiotoxicity: Is it a Personalized Risk?
Current Drug Targets From Anreps Phenomenon to Myocardial Hypertrophy: Role of the Na+/H+ Exchanger
Current Cardiology Reviews Role of Heme Oxygenase-1 in Cardiovascular Function
Current Pharmaceutical Design Proteomic and Bioinformatic Analysis of Trypanosoma cruzi Chemotherapy and Potential Drug Targets: New Pieces for an Old Puzzle
Current Drug Targets Light Chain Amyloidosis – Current Findings and Future Prospects
Current Protein & Peptide Science Methods to Evaluate the Inhibition of TTR Fibrillogenesis Induced by Small Ligands
Current Medicinal Chemistry Mild Improvement in Mitochondrial Function After a 3-Year Antiretroviral Treatment Interruption Despite Persistent Impairment of Mitochondrial DNA Content
Current HIV Research Nimodipine Reappraised: An Old Drug With a Future
Current Neuropharmacology Endocrine Therapies and QTc Prolongation
Current Drug Safety Nitric Oxide: State of the Art in Drug Design
Current Medicinal Chemistry Prevention of Sudden Cardiac Death in Hemodialysis Patients
Cardiovascular & Hematological Disorders-Drug Targets Omega-3 Fatty Acid Treatment Combined with Chemotherapy to Prevent Toxicity, Drug Resistance, and Metastasis in Cancer
Current Drug Targets Ivabradine: A Current Overview
Current Clinical Pharmacology Advancement of Mechanisms of Coxsackie Virus B3-Induced Myocarditis Pathogenesis and the Potential Therapeutic Targets
Current Drug Targets Mediterranean Diet, Brain and Muscle: Olive Polyphenols and Resveratrol Protection in Neurodegenerative and Neuromuscular Disorders
Current Medicinal Chemistry Antithrombotic Treatment in Cardiomyopathies
Current Pharmaceutical Design Von Willebrand Factor and Cardiovascular Disease: From a Biochemical Marker to an Attractive Therapeutic Target
Current Vascular Pharmacology The Failing Heart in Pediatric Dilated Cardiomyopathy Caused by Excessive Water Drinking: A Case Report and Brief Review
New Emirates Medical Journal Cardiovascular Effects of Neuregulin-1/ErbB Signaling: Role in Vascular Signaling and Angiogenesis
Current Pharmaceutical Design Molecular Mechanisms of Inherited Arrhythmias
Current Genomics